NIBSC code
Product name
21/186
Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)
21/190
Influenza Virus Infectious X-361A (H3N2)
21/148
Influenza Virus Infectious X-359 (H3N2)
21/150
Influenza Virus Infectious X-359A (H3N2)
21/192
Influenza Virus Infectious BX-97A (B-Victoria Lineage)
21/194
Influenza Virus Infectious A/Hong Kong/2671/2019
21/196
Influenza Virus Infectious IVR-224 (H3N2)
21/158
Influenza Virus Infectious BX-93B (B-Victoria Lineage)
19/160
Influenza Virus Infectious A/California/7/09 44430 E6
21/204
Influenza Virus Infectious IVR-227 (H3N2)
21/214
Influenza Virus Infectious A/Darwin/9/2021 (H3N2)
21/226
Influenza Virus Infectious NIB-127 (H3N2)
21/228
Influenza Virus Infectious NIB-126 (H3N2)
21/216
Influenza Virus Infectious BVR-25 (B-Victoria Lineage)
21/246
Influenza Virus Infectious IVR-228 (H3N2)
21/244
Influenza Virus Infectious B/Michigan/1/2021 (B-Victoria Lineage)
21/212
21/240
Influenza Virus Infectious CNIC-1909 (H1N1)
21/234
Working reagent for anti-SARS-CoV-2 immunoglobulin
100976
pCAGGS-SARS-CoV-2-Spike
100978
VeroE6/TMPRSS2
100980
SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020
100982
SARS-CoV-2 Nucleoprotein
100985
pCAGGS_SARS-CoV-2_Spike D614G
100986
pCAGGS-SARS-CoV-2-Spike Bristol Deletion
100987
Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
100988
Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
100989
pCRII-SARS-CoV-2 (5’UTR-NSP2)
100991
pCRII-SARS-CoV-2 (NSP4-NSP8)
100992
100994
pCRII-SARS-CoV-2 (NSP15-NSP16)
100996
pCRII-SARS-CoV-2 (ORF3a-ORF6)
100998
SARS-CoV-2 infectious virus (CVR-GLA 1)
100999
SARS-CoV-2 infectious virus(CVR-GLA 2)
101000
SARS-CoV-2 infectious virus(CVR-GLA 3)
101001
VeroE6-ACE2
101003
VeroE6-ACE2-TMPRSS2
101004
A549-ACE2-TMPRSS2
101005
A549-ACE2 Clone8
101006
A549-ACE-2 Clone 8-TMPRSS2
101007
SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020
101008
HEK293T-ACE2-TMPRSS2
101009
Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)
101010
Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)
101011
Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC)
101019
VOC-202012/01 (B.1.1.7 lineage) lot 26012021
101023
pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021
101024
pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021
101027
Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021
101029
SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021
101022
SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4
101025
4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2
4024
Antisera to SARS CoV-1 S1 Protein (Rabbit)
0688
SARS CoV-1 spike S1 protein
21/B777
Ferritin Quality control Serum Sample 1
20/B762
QCRHIVQC2
21/180
Meningococcal Capsular Group W polysaccharide
15/272
ICS Positive Control-Lymphocytes